A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

Clinical trial NCT06783816 · RECRUITING

Trial details

NCT number: NCT06783816
Sponsor: Shanxi Bethune Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia Lymphoma,Non-Hodgkin Relapsed Refractory Multiple Myeloma

Start date: 2023-12-01
Primary completion: 2028-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.